Print Friendly Page

Protocol No. OS12601

Principal Investigator Albertini, Mark

Phase N/A

Age Group Adult

Scope Local

Sponsor Type Institutional

Title T Cell Mutants as BioMarkers in Human Melanoma

Objective We are trying to increase our understanding of both human melanoma and human vitiligo so that better monitoring and treatment can be developed for patients with melanoma.

Description You are invited to participate in a research program by donating blood for experimental purposes. Your blood will be used in laboratory experiments to study subjects with melanoma and/or subjects with vitiligo. This study also studies advanced melanoma patients before and after treatment with Ipilimumab, a new treatment for that disease.

Key Eligibility
  • Metastatic melanoma patients (10 need to be before and after treatment with Ipilimumab).
  • Established diagnosis of vitiligo, with or without a current diagnosis of melanoma.
  • Normal control blood donors without a known diagnosis of melanoma or vitiligo.

  • Applicable Disease Sites Melanoma/Skin cancer

    Status Open

    Participating Institutions UW Hospital and Clinics